Lonza’s Hygiene & Preservation business revealed that its Lonzagard R-82 family of disinfectants is now EPA approved to combat Carbapenem-Resistant Enterobacteriaceae (CREs). Untreatable and hard-to-treat infections from CRE bacteria are on the rise among patients in medical facilities.
The Lonzagard R-82 family includes economical concentrates and convenient, ready-to-use disinfectants that are ideal for all types of healthcare facilities.
“Lonza aims to provide solutions that disinfect hard surfaces to kill CRE throughout healthcare facilities. Our highly effective disinfectants are a vital tool to kill disease-causing bacteria and viruses on hard surfaces that if left untreated can lead to the spread of hospital-acquired infections,” said Craig Carter, N.A. marketing manager for Lonza’s Hygiene business, which is a part of the company’s Consumer Care organization.
More info: www.lonzabiocides.com